about
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA clusterStructure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genesMenin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaLncRNAs and immunity: watchdogs for host pathogen interactions.The Pbx interaction motif of Hoxa1 is essential for its oncogenic activityCaudal genes in blood development and leukemia.Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.Long non-coding RNAs and control of gene expression in the immune system.MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.Challenges and opportunities in targeting the menin-MLL interaction.Small non-coding RNA deregulation in endometrial carcinogenesis.Transcriptome Profiling of Pediatric Core Binding Factor AML.Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.Long non-coding RNAs and cancer: a new frontier of translational research?Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays.MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cellsThe hemangioblast: from concept to authentication.Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesisThe role of HOX genes in normal hematopoiesis and acute leukemia.The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).Glycogen synthase kinase-3 and leukemia: restoring the balance.MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinomaReduction in Cell Viability and in Homeobox Protein Levels Following in Vitro Exposure to δ-tocopherol in Acute Myeloid Leukemia.CTCF boundary remodels chromatin domain and drives aberrant gene transcription in acute myeloid leukemia
P2860
Q24657435-B6FB5988-487A-4696-A6DA-DDEF240D789BQ27658663-8D14A24B-AB04-406E-AF98-C5E2420BCF95Q28592846-8B50FEB8-5CDB-4ADD-93DF-5EDC40D8E915Q30425903-1E308148-BC52-4978-9F24-0BA30BF4BE9DQ33608858-11872F6A-2E89-4BB5-A2E5-C655E8FAD152Q34034783-0373E1FB-9E80-40C4-8FB8-2A4A75ABFEF6Q34294578-A1C87851-6EFC-4F6A-82B9-D49AFC0504E5Q34395225-87F230CD-B74A-4F23-A73A-8D0AAEB070ABQ34616243-E180FFA8-55C5-487A-B87C-5F53ECFF1857Q34826310-EC5A9967-C822-4DF7-BC5F-AB4FA3AA4997Q35122366-14DBACBE-255B-455C-A7AB-49F6D828C9F8Q35741534-F3F56511-D211-4863-8E47-A4DA1FEE1F8DQ35784721-A4F13F75-29E8-4AAF-94CE-BDC74A5C1D48Q36098242-2860D9B9-4607-46AA-A013-F33DBBC12431Q36208103-91FD5E94-BCA7-47B2-89B0-E95EBE75CC35Q36390565-D56E9174-A5ED-4A61-8F12-F7985C3DDD64Q36544957-2BB17D76-CC4E-48F8-8173-7ACB11AED98CQ37849265-9EBF2BA3-1B57-4848-A8B9-DA95B988627EQ38006676-6354F958-6485-4214-89D0-3726389143BAQ38065068-F6F409DF-D7D9-4D42-8DA8-95C31026176BQ38976675-9B515C3B-B59A-4025-9BDA-95F8580F0298Q41728445-6FBC6C23-E969-46CF-AF12-515ACBB1863EQ42315789-6C8B6218-D87C-4393-93AB-1EC3B1A068DFQ44432135-595FF37F-19E3-4191-A776-9CFA08C471E0Q58714124-01FA77B0-8EC5-43C0-907C-92F145974A1C
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HOX deregulation in acute myeloid leukemia
@ast
HOX deregulation in acute myeloid leukemia
@en
HOX deregulation in acute myeloid leukemia
@nl
type
label
HOX deregulation in acute myeloid leukemia
@ast
HOX deregulation in acute myeloid leukemia
@en
HOX deregulation in acute myeloid leukemia
@nl
prefLabel
HOX deregulation in acute myeloid leukemia
@ast
HOX deregulation in acute myeloid leukemia
@en
HOX deregulation in acute myeloid leukemia
@nl
P2860
P356
P1476
HOX deregulation in acute myeloid leukemia
@en
P2093
Kim L Rice
P2860
P304
P356
10.1172/JCI31861
P407
P577
2007-04-01T00:00:00Z